PharmTech News

Articles

The airlock solution for cleanrooms offers contamination controls for a highly controlled environment.

AES Clean Technology Launches CleanLock Module

Feliza Mirasol is the science editor for 

WMFTS has launched WMArchitect, a single-use product line that offers ready-to-use single-use assemblies and custom-designed workflows for biopharma fluid management. 

WMFTS Showcases New Single-Use Solutions Designed to Optimize Fluid Management 

Charles River has entered into separate agreements with Axovia Therapeutics and Ship of Theseus to offer plasmid DNA manufacturing services for a gene therapy and a lead candidate program, respectively.

Charles River to Provide pDNA Manufacturing Services in Two Deals

With the launch of a new manufacturing service, Memel Biotech will offer services for discovery through to formulation for advance therapy medicinal products.

Memel Biotech to Offer ATMP Manufacturing at Lithuania Site

Under a collaboration agreement, Lonza will manufacture sabirnetug, Acumen Pharmaceuticals' mAb in clinical development for treating Alzheimer’s disease.

Lonza Forms Agreement to Manufacture Acumen Pharmaceuticals’ AD mAb Therapy 

Pharmaceutical Technology gives a brief overview of some of developments in manufacturing facilities, including news from W.R. Grace & Co, ITT Inc, and SMC.

Manufacturing Facility Updates

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Videos

Can Cellares deliver on the goal to meet total patient demand for cell therapies globally? CEO Fabian Gerlinghaus discusses.

Automation of Clinical Data Key in Meeting Cell and Gene Therapy Demand

Univercells and Altamira Therapeutics are collaborating on nanoparticle-delivered mRNA vaccines, while Andelyn Biosciences and Grace Science are partnering on novel therapies for NGLY1 deficiency.

Univercells and Andelyn Biosciences Form Separate Drug Development Partnerships

The Vacaville, Calif., site acquisition gives Lonza one of the largest biologics manufacturing sites for mammalian cell-based therapies worldwide.

Roche Sells Large-Scale Biologics Manufacturing Site in US to Lonza for $1.2 Billion

CDMO White Raven aims to reduce contamination risk and gain the capability to handle multiple product formats with the installation of Cytiva’s SA25 Aseptic Filling Workcell.

Supplier News